BioPlus Acquisition (BIOSU) Stock Price, News & Analysis

Company Overview

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

Key Stats

• Today's Range: $10.80 to $10.84
• 50-Day Range: $10.80 to $10.90
• 52-Week Range: $10.06 to $11.56
• Volume: 700 shs
• Average Volume: 3,141 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIOSU Stock Analysis - Frequently Asked Questions

When did BioPlus Acquisition IPO?

BioPlus Acquisition (BIOSU) raised $200 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 20,000,000 shares at $10.00 per share.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Financial Services
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BIOSU
• CIK: 1856653
• Web: bioplusspac.com
• Phone: 212-287-4092
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A